At the end of the bill (preceding the amendment to the long title), insert the following new section: \ SEC. 5. ACTIONS INVOLVING WEIGHT-LOSS PRODUCTS. \ Notwithstanding any other provision of this Act, this Act shall not apply to an action alleging that a product claiming to assist in weight loss caused heart disease, heart damage, primary pulmonary hypertension, neuropsychological damage, or any other complication which may also be generally associated with a person's weight gain or obesity.

Ask AI
Amendment Number
477
Description
At the end of the bill (preceding the amendment to the long title), insert the following new section: \ SEC. 5. ACTIONS INVOLVING WEIGHT-LOSS PRODUCTS. \ Notwithstanding any other provision of this Act, this Act shall not apply to an action alleging that a product claiming to assist in weight loss caused heart disease, heart damage, primary pulmonary hypertension, neuropsychological damage, or any other complication which may also be generally associated with a person's weight gain or obesity.
Purpose
An amendment numbered 10 printed in the Congressional Record to provide that the bill would not apply to civil actions that allege a product claiming to assist in weight loss caused heart disease, heart damage, primary pulmonary hypertension, neuropsychological damage, or any other complication which may be generally associated with a person's weight gain or obesity.
Congress
108
Type
HAMDT
Latest Action Date
Mar 10, 2004
Latest Action Text
On agreeing to the Jackson-Lee (TX) amendment (A009) Failed by recorded vote: 166 - 250 (Roll no. 52).
Latest Action Time
17:34:50
Submitted Date
Mar 10, 2004
Chamber
House of Representatives
Update Date
Feb 3, 2022
Amendment 477 — Informed